Your browser doesn't support javascript.
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff, Burkhard; Müller, Barbara; Elling, Roland; Renk, Hanna; Meissner, Peter; Hengel, Hartmut; Garbade, Sven F; Kieser, Meinhard; Jeltsch, Kathrin; Grulich-Henn, Jürgen; Euler, Julia; Stich, Maximilian; Chobanyan-Jürgens, Kristine; Zernickel, Maria; Janda, Ales; Wölfle, Lena; Stamminger, Thomas; Iftner, Thomas; Ganzenmueller, Tina; Schmitt, Christian; Görne, Tessa; Laketa, Vibor; Olberg, Sylvia; Plaszczyca, Anna; Cortese, Mirko; Bartenschlager, Ralf; Pape, Constantin; Remme, Roman; Huzly, Daniela; Panning, Marcus; Weigang, Sebastian; Giese, Sebastian; Ciminski, Kevin; Ankerhold, Jakob; Kochs, Georg; Schwemmle, Martin; Handgretinger, Rupert; Niemeyer, Charlotte M; Engel, Corinna; Kern, Winfried V; Hoffmann, Georg Friedrich; Franz, Axel R; Henneke, Philipp; Debatin, Klaus-Michael; Kräusslich, Hans-Georg.
  • Tönshoff B; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Müller B; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Elling R; Center for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
  • Renk H; Institute for Immunodeficiency, University Medical Centre and Faculty of Medicine Freiburg, Freiburg, Germany.
  • Meissner P; University Children's Hospital Tübingen, Tübingen, Germany.
  • Hengel H; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Garbade SF; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Kieser M; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Jeltsch K; Institute for Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg, Heidelberg, Germany.
  • Grulich-Henn J; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Euler J; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Stich M; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Chobanyan-Jürgens K; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Zernickel M; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Janda A; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Wölfle L; Pediatric Clinical-Pharmacological Trial Centre (paedKliPS), University Hospital Heidelberg, Heidelberg, Germany.
  • Stamminger T; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Iftner T; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Ganzenmueller T; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Schmitt C; Institute of Virology, University of Ulm, Ulm, Germany.
  • Görne T; Institute for Medical Virology, University Hospital of Tübingen, Tübingen, Germany.
  • Laketa V; Institute for Medical Virology, University Hospital of Tübingen, Tübingen, Germany.
  • Olberg S; Center for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
  • Plaszczyca A; Center for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
  • Cortese M; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Bartenschlager R; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Pape C; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
  • Remme R; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
  • Huzly D; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
  • Panning M; Heidelberg Collaboratory for Image Processing, Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany.
  • Weigang S; European Molecular Biology Laboratory, Heidelberg, Heidelberg, Germany.
  • Giese S; Heidelberg Collaboratory for Image Processing, Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany.
  • Ciminski K; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Ankerhold J; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Kochs G; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Schwemmle M; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Handgretinger R; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Niemeyer CM; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Engel C; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Kern WV; Institute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Hoffmann GF; University Children's Hospital Tübingen, Tübingen, Germany.
  • Franz AR; Center for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
  • Henneke P; Centre for Paediatric Clinical Studies at the University Children's Hospital Tübingen, Tübingen, Germany.
  • Debatin KM; Department of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg, Germany.
  • Kräusslich HG; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
JAMA Pediatr ; 175(6): 586-593, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1044436
ABSTRACT
Importance School and daycare closures were enforced as measures to confine the novel coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young children may play a key role in severe acute respiratory coronavirus 2 (SARS-CoV-2) spread. Given the grave consequences of contact restrictions for children, a better understanding of their contribution to the COVID-19 pandemic is of great importance.

Objective:

To describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years, compared with a corresponding parent of each child, in a population-based sample. Design, Setting, and

Participants:

This large-scale, multicenter, cross-sectional investigation (the COVID-19 BaWü study) enrolled children aged 1 to 10 years and a corresponding parent between April 22 and May 15, 2020, in southwest Germany. Exposures Potential exposure to SARS-CoV-2. Main Outcomes and

Measures:

The main outcomes were infection and seroprevalence of SARS-CoV-2. Participants were tested for SARS-CoV-2 RNA from nasopharyngeal swabs by reverse transcription-polymerase chain reaction and SARS-CoV-2 specific IgG antibodies in serum by enzyme-linked immunosorbent assays and immunofluorescence tests. Discordant results were clarified by electrochemiluminescence immunoassays, a second enzyme-linked immunosorbent assay, or an in-house Luminex-based assay.

Results:

This study included 4964

participants:

2482 children (median age, 6 [range, 1-10] years; 1265 boys [51.0%]) and 2482 parents (median age, 40 [range, 23-66] years; 615 men [24.8%]). Two participants (0.04%) tested positive for SARS-CoV-2 RNA. The estimated SARS-CoV-2 seroprevalence was low in parents (1.8% [95% CI, 1.2-2.4%]) and 3-fold lower in children (0.6% [95% CI, 0.3-1.0%]). Among 56 families with at least 1 child or parent with seropositivity, the combination of a parent with seropositivity and a corresponding child with seronegativity was 4.3 (95% CI, 1.19-15.52) times higher than the combination of a parent who was seronegative and a corresponding child with seropositivity. We observed virus-neutralizing activity for 66 of 70 IgG-positive serum samples (94.3%). Conclusions and Relevance In this cross-sectional study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children aged 1 to 10 years. Accordingly, it is unlikely that children have boosted the pandemic. This SARS-CoV-2 prevalence study, which appears to be the largest focusing on children, is instructive for how ad hoc mass testing provides the basis for rational political decision-making in a pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Adult / Aged / Child / Child, preschool / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: JAMA Pediatr Year: 2021 Document Type: Article Affiliation country: Jamapediatrics.2021.0001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Adult / Aged / Child / Child, preschool / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: JAMA Pediatr Year: 2021 Document Type: Article Affiliation country: Jamapediatrics.2021.0001